In this article, we report the total chemical synthesis of human lysozyme. Lysozyme serves as a widespread model system in various fields of biochemical research, including protein folding, enzyme catalysis, and amyloidogenesis. The 130-aa wild-type polypeptide chain of the human enzyme was assembled from four polypeptide segments by using native chemical ligation in a fully convergent fashion. Key to the assembly strategy is the application of the recently developed kinetically controlled ligation methodology, which provides efficient control over the ligation of two peptide ␣ thioesters to yield a unique product. This result enables the facile preparation of a 64-residue peptide ␣ thioester; this segment is joined by native chemical ligation to a 66-aa Cys peptide, to yield the target 130-aa polypeptide chain. The synthetic polypeptide chain was folded in vitro into a defined tertiary structure with concomitant formation of four disulfides, as shown by 2D TOCSY NMR spectroscopy. The structure of the synthetic human lysozyme was confirmed by high-resolution x-ray diffraction, giving the highest-resolution structure (1.04 Å) observed to date for this enzyme. Synthetic lysozyme was obtained in good yield and excellent purity and had full enzymatic activity. This facile and efficient convergent synthesis scheme will enable preparation of unique chemical analogs of the lysozyme molecule and will prove useful in numerous areas of lysozyme research in the future. 
L
ysozyme is possibly one of the best studied enzymes. The x-ray structure of hen egg-white lysozyme, initially reported in 1965, was the first high-resolution 3D structure of an enzyme molecule (1) . Since then the protein has served as a model system for the study of protein folding and misfolding, enzyme catalysis and mechanism, x-ray crystallography, enzyme evolution, and protein engineering (2) (3) (4) (5) (6) (7) (8) (9) . Moreover, human lysozyme recently has attracted considerable interest because certain mutations in the enzyme were shown to render the protein amyloidogenic (10, 11) .
Despite extensive genetic, structural, and physico-chemical studies carried out over the last 50 years, many questions regarding lysozyme folding, catalysis, and amyloid fibril formation remain unsolved, unsatisfactorily explained, or controversial. This deficit is at least in part attributable to the limited means that could be used to modify the chemical structure of the lysozyme molecule. More powerful and versatile control over the structure of the enzyme is required for a detailed understanding of the properties of the protein on the molecular or atomic scale. Chemical protein synthesis has emerged as a powerful tool in this respect, especially because it grants nearly absolute control over the covalent structure of an enzyme molecule (12) (13) (14) . Given the widespread and longlasting interest in lysozyme research, it is not surprising that for exactly these reasons chemical synthesis of the full-length protein has been envisioned (and attempted) as early as the 1970s (15, 16) . However, these early experiments were unsuccessful, and despite significant progress made in the field, robust chemical access to the Ϸ130-aa family of lysozyme proteins has not been established so far.
Modern approaches to the chemical synthesis of proteins involve the synthesis by stepwise solid-phase peptide synthesis (SPPS) of relatively small (Ͻ50-residue) peptide segments, which span the entire sequence of the polypeptide chain of the protein. These unprotected segments then are linked by chemical ligation reactions to give the full-length polypeptide, which then is folded in vitro to form the active protein. Critical to this synthetic strategy was the development of chemical ligation approaches, which made possible the chemoselective linking of unprotected peptide segments in good yield (17) . Native chemical ligation (NCL) (18) is the most successful chemoselective reaction developed so far and has enabled the synthesis of a number of proteins, which often were equipped with nonnative features (such as biophysical probes, backbone modifications, D-amino acid residues, or glycan mimetics) to address specific experimental questions (19) (20) (21) (22) . NCL involves the reaction of an unprotected peptide ␣ thioester with another unprotected peptide carrying an N-terminal cysteine. Initial reversible transthioesterification between the sulfhydryl group of the Nterminal cysteine and the peptide ␣ thioester gives a thioester-linked intermediate, which spontaneously rearranges in a rapid second step to form a native peptide bond (18) .
Most proteins synthesized so far by NCL have been constructed from merely two peptide segments, thus limiting chemical access to target proteins of Ϸ100 or fewer amino acids (13) . To gain synthetic access to longer polypeptide chains, ligation of a larger number of peptide segment building blocks must be used. To date, essentially all three-segment syntheses have been performed in a rather inflexible fashion by sequential ligations starting from the Cterminal peptide segment with extension toward the N terminus. Multiple rounds of ligation and intermediate product purification typically result in substantial losses. This problem has been minimized by carrying out several ligations in a one-pot manner (23) , but the rapid build up of impurities effectively limits such one-pot syntheses to only three segments. For these reasons, a more efficient convergent synthetic strategy is needed.
We recently introduced the concept of kinetically controlled ligation (KCL) (24) , which enables the reaction of a peptide thioarylester and a Cys-peptide thioalkylester to yield a single product. This process enables the synthesis of a protein in a fully convergent fashion (24) . In a convergent synthesis (Scheme 1), each starting peptide segment is approximately the same number of chemical transformations away from the final product (25) . This This article is a PNAS direct submission.
Abbreviations: SPPS, solid-phase peptide synthesis; NCL, native chemical ligation; KCL, kinetically controlled ligation; MPAA, 4-mercaptophenylacetic acid; Thz, 1,3-thiazolidine-4-carboxylic acid; MESNA, sodium 2-mercaptoethanesulfonate; obsd., observed; calcd., calculated; TCEP, Tris(2-carboxyethyl)phosphine hydrochloride; LC, liquid chromatography; RP-HPLC, reversed-phase HPLC; ESI, electrospray ionization; TFA, trifluoroacetic acid. fact becomes particularly significant when multiple analogs of a given target have to be prepared and the sites of modification are scattered across the entire sequence. Convergent synthesis, in principle, also will increase final yields when compared with sequential assembly tactics (25) .
In this article, we report the reproducible convergent chemical synthesis of human lysozyme, a 130-aa residue protein molecule containing four disulfides. The structure of the synthetic protein was confirmed by mass spectrometry, 2D TOCSY NMR, and high-resolution (1.04 Å) x-ray diffraction. The synthetic enzyme had full catalytic activity.
Results and Discussion
Designing a Synthesis of Human Lysozyme. Our convergent strategy for the total chemical synthesis of the human lysozyme molecule is shown in Scheme 1. Human lysozyme contains eight cysteines, which are distributed evenly across the polypeptide chain and form four disulfide bonds in the folded enzyme molecule (Scheme 1). All cysteines could serve as potential ligation sites. We envisioned a final ligation of two large peptide segments to give the 130-residue polypeptide chain. To optimize the synthesis, we used four peptide segments of approximately equal length: peptides 1-29, 30-64, 65-94, and 95-130. These peptides are of convenient length (Ϸ29-35 aa), and their preparation by optimized stepwise Boc chemistry SPPS (26) was expected to be straightforward. In terms of reaction rates, the chosen ligation sites (Met 29 64 ]-␣ thioalkylester. The peptide ␣ thioarylester was generated by transthioesterification from the corresponding ␣ thioalkylester by using an excess of 4-mercaptophenylacetic acid (MPAA). The latter compound recently was shown to be a superior thiol catalyst to the established and widely used thiophenol, and it is particularly useful for the facile conversion of a peptide ␣ thioalkylester to the corresponding peptide ␣ thioarylester (28 . In this case, the N-terminal Cys 65 needs to be protected temporarily, which can be achieved by using 1,3-thiazolidine-4-carboxylic acid (Thz) (23, 29) . In the convergent synthetic scheme, the full-length product [Lys ] is obtained by ligating the two halves of the target polypeptide, after which folding and disulfide formation are used to yield the native enzyme molecule.
Synthesis of Peptide Segment Building Blocks. Peptide segments were prepared by using in situ neutralization Boc chemistry SPPS protocols as described in ref. 26 . Segments 1-29, 30 -64, and 65-94 were prepared on modified TAMPAL resins generating C-terminal ␣ thioalkylesters upon HF cleavage (27) . Segment 95-130 carrying a free ␣ carboxyl group was synthesized on ϪOCH 2 -Pam resin. All five tryptophans were incorporated as Trp(CHO), and His 78 was incorporated as His(Dnp). As expected, both the Trp(CHO) and His(Dnp) side-chain protecting groups were unaffected by the HF/pcresol treatment used for deprotection and cleavage from the resin. These protecting groups typically are removed under conditions that are not fully compatible with thioesters and thus were removed at later stages of the synthesis.
During our initial studies on ligation reactions between Cys-containing lysozyme peptides, we observed unusually slow reaction rates (Ͼ24 h until completion), which we attributed to the large number of unprotected internal cysteines forming unproductive internal thioesters (thiolactones), which slow down product formation. This finding seemed to be even more pronounced when preformed ␣ thioarylesters, which are more activated toward nucleophilic attack than standard ␣ thioalkylesters are, were used (28, 30) . In one particular case, incubation of a peptide ␣ thioester containing a single ''internal'' cysteine residue under ligation conditions led to almost quantitative thiolactone formation within seconds. Although such a side reaction would only slow down a normal NCL reaction, we reasoned that the effect of thiolactone formation on a KCL would be more deleterious because kinetic control relies on the (Fig. 1B) (Fig. 1C) .
The formation of such unwanted thioester species is typical of KCL and represents an undesirable side reaction. Especially formation of the branched thioester 4 can be expected to be the principal reason for nonquantitative KCL (aside from oligomerization and cyclization) because it dissipates precious activated peptide ␣ thioarylester. Fig. 3 for analytical data). The reaction was complete within 12 h. After solid-phase extraction and elution into 50% (vol/vol) aceonitrile-water containing 0.1% (vol/vol) trifluoroacetic acid (TFA), the S-Acm side-chain protecting groups subsequently were removed by treatment with a large excess of AgOAc (35 equiv. per S-Acm group) over 10 h. Silver thiolates were converted to the free thiols by adding a large excess of DTT; a precipitate was formed immediately (consisting of Ag-DTT complexes). In previous attempts to prepare lysozyme by total chemical synthesis, the removal of S-Acm protecting groups had proved problematic (15) . Modern MALDI-MS allowed us rapidly to optimize removal of the Acm groups. Acm deprotection initially was studied on model peptides, † Thiolactone formation of this type could preclude the further C-terminal activation, as the thioaryl ester, of the product of a KCL. ‡ This use of the S-Acm group, depending on the number and location of Cys residues, may preclude use of the S-Acm for directed disulfide formation in the final product protein. comparing AgOAc and Hg(OAc) 2 deprotection protocols under otherwise similar conditions. In our hands, AgOAc-mediated Acm removal was significantly slower than Acm deprotection by Hg(OAc) 2 . However MALDI-MS analysis indicated that decomposition of the formed Hg-thiolate compounds turned out to be more challenging and required longer reaction times and a larger excess of DTT when compared with the corresponding Ag-thiolates (data not shown). For this reason, we chose to stick to the AgOAc protocol, which also has been reported to be milder in the presence of sensitive amino acid residues (31, 32) .
Assembly of the C-Terminal
Tryptophan formyl protecting groups (five in total) then were removed by treating the crude peptide with 20% (vol/vol) piperidine and 38% (vol/vol) 2-mercaptoethanol in aqueous guanidine hydrochloride solution for 40 min at 0°C. The HPLC-purified fully deprotected and reduced 130-aa polypeptide [supporting information (SI) Fig. 6 A] was obtained in reasonable yield [28% overall yield for (ligation ϩ removal of Acm and formyl protecting groups ϩ HPLC purification), based on the starting reactants 5 and 8; ESI-MS obsd. average mass, 14,700.2 Ϯ 1.5 Da; calcd., 14,700.7 Da].
Folding, Disulfide Formation, and Product Characterization. The purified 130-residue polypeptide chain was folded by dilution into buffer containing a redox system consisting of 5 mM oxidized glutathione and 2 mM DTT at pH 8 (final peptide concentration after dilution was 0.175 mg/ml). After 14 h, formation of the correctly folded structure was revealed on LC analysis by the appearance of a sharp peak eluting at earlier retention time (SI Fig.  6 ). Such a shift in retention time has been observed in numerous cases upon (re)folding of disulfide cross-linked globular proteins and reflects the burial of hydrophobic residues within the protein core. The sharp peak was preceded by a poorly resolved unidentifiable compound mixture probably representing nonnative disulfide isomers of the lysozyme molecule. ESI-MS analysis of the principal peak revealed a mass of 14,693.4 Ϯ 0.7 Da (Fig. 4) . This value corresponds to a loss of 6.8 Ϯ 2.2 Da, which is in excellent agreement with the formation of four disulfides and the concomitant loss of eight protons (calcd., 14,692.7 Da; average isotopes). Folded synthetic lysozyme was purified from the crude folding solution by RP-HPLC and was recovered in good yield (40%). ESI-MS, MALDI-MS, and RP-HPLC analysis indicated high purity of the synthetic material ( Fig. 4A and SI Figs. 6C and 7) .
The conformational homogeneity of the synthetic protein was demonstrated by 1D 1 H-NMR and 2D TOCSY 1 H-1 H NMR spectroscopy under solution conditions. SI Fig. 8 A and B shows the dispersion of chemical shifts in the amide/aromatic and aliphatic spectral regions of the 1D 1 H-NMR spectrum. The 2D TOCSY 1 H-1 H NMR spectrum of the aliphatic spin systems is shown in Fig.  4B . The observed chemical shifts are identical to those assigned in the spectrum of biosynthetic human lysozyme (33, 34) and indicate native folding and the absence of detectable misfolded conformations in the synthetic sample.
The synthetic enzyme was crystallized, and its 3D structure was determined by x-ray diffraction. Data were collected to a resolution of 1.04 Å (SI Table 1 ). The structure was solved by rigid-body approximation followed by restrained mixed anisotropic/isotropic refinement to an R factor of 0.136 and an R free of 0.151 for 50-1.04 Å data by using a previously reported structure as a starting model (PDB ID code 1JSF) (Fig. 5) (35) . Superposition of the obtained structure with previous structures obtained from biosynthetic human lysozyme (35) revealed identical covalent structures and highly similar native folds.
To unequivocally demonstrate anticipated enzymatic function, the synthetic protein product was tested for lysozyme activity by using a well established assay (36) . In this assay, the clearance of a bacterial cell-wall suspension as a result of lysozyme-mediated cell-wall degradation is measured spectrophotometrically. Addition of a sample of the synthetic protein to a suspension of Micrococcus lysodeikticus cells led to a rapid decrease in turbidity, revealing that enzymatically active protein indeed had been obtained (Fig. 4C) . The specific activity of the synthetic material was determined as 72,250 Ϯ 1,000 units/mg of sample, which is comparable to reported values for commercially available recombinant material of high purity.
Based on these biochemical and structural data, we conclude that chemically synthesized human lysozyme is a homogeneous preparation identical to human lysozyme isolated from biological sources. A typical preparation of synthetic lysozyme yielded Ϸ2.5 mg of native enzyme.
§ This amount of enzyme was more than sufficient to perform all biophysical and biochemical experiments described above.
Conclusions
In this article, we report on efficient and robust total chemical synthesis of human lysozyme. The 130-aa residue protein molecule § An overall yield for the synthesis of 5.6% can be calculated based on the limiting reactants, peptides 30 -64 and 95-130. The effective yield is reduced 2-fold further if the conversion of the peptide thioalkyl to thioaryl esters is taken into account. 
